Description

CJC-1295 + Ipamorelin (No DAC) – Research Peptide Blend Reference Material

CJC-1295 (No DAC) (also known as Modified GRF 1-29) combined with Ipamorelin forms a potent, dual-acting research formulation. This blend is extensively studied in preclinical models to explore synergistic signaling pathways involving growth hormone-releasing hormone (GHRH) receptor binding and ghrelin/growth hormone secretagogue receptor (GHS-R) activation. The combination is widely evaluated for its role in cellular repair mechanisms, protein synthesis pathways, and growth hormone pulsatility dynamics without altering baseline prolactin or cortisol levels.

Research-Only Use This material is strictly intended for laboratory research and laboratory analytical purposes only. It is not intended for human consumption, clinical diagnostic procedures, or veterinary administration. No claims are made regarding its safety, efficacy, or therapeutic applicability.

Disclaimer The information provided is curated strictly for scientific education and research reference. It is not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated or approved by the FDA or any equivalent regulatory agency.

Terms of Sale By purchasing this item, you confirm that you are a qualified researcher, institution, or laboratory operating in full compliance with all applicable local, state, and federal regulations. The seller assumes no liability for misuse, improper handling, unauthorized application, or unlawful distribution, and shall not be responsible for any resulting loss, injury, claim, or damage.